Navigation Links
New York Law Firm Files Lawsuit Against Manufacturer of Zicam Nasal Spray and Drugstore Chain That Sold Product
Date:7/8/2009

Leading personal injury law firm files complaint, alleging permanent damage to Long Island man's sense of smell and taste

Mineola, N.Y.(Lexis Nexis) July 8, 2009 -- Marc Grossman, senior partner of leading national personal injury law firm of Sanders Viener Grossman, LLP, in Mineola, N.Y., today announced that his firm has filed a civil lawsuit against the manufacturer of the popular Zicam nasal spray and the national drugstore chain that sold the product to a New York man who is alleging permanent injuries from his use of Zicam.

The lawsuit, Coleman et al v. Matrixx Intiatives, Inc. et al (Case Number 2:09-cv-2838), was filed last Thursday in the U.S. District Court, Eastern District of New York. The complaint alleges that Donald Coleman, a Bohemia, N.Y. resident, purchased a bottle of "Zicam Cold Remedy Nasal Spray" at a CVS Pharmacy store. After using the spray for about a week, and although the label stated it was "safe and effective" and a "patented homeopathic" remedy for cold symptoms, Mr. Coleman claims that he permanently lost his senses of smell and taste.

On June 16, 2009, the U.S. Food and Drug Administration (FDA) issued a public health advisory warning consumers to stop using and discard Zicam Cold Remedy Nasal Spray products, because the agency received greater than 130 reports of Anosmia, the medical term for a loss of smell and taste. As an over-the-counter product, neither the Zicam Cold Remedy Nasal Spray nor its labeling has ever been approved by the FDA.

"This is a clear example of an unregulated and unsafe product masquerading as a product that
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. CareFusion Files Amended Form 10 Registration Statement With SEC
2. Novo Nordisk Insulin Analogs Have Proven Safety Profiles
3. Discus Dental Files Suit to Protect BriteSmile(R) Trademark
4. WuXi PharmaTech Files 2008 Annual Report on Form 20-F
5. Simcere Pharmaceutical Group Files Annual Report on Form 20-F
6. Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
7. Watson Files FDA Application for Generic Mucinex(R) D
8. Profiles International Releases New Report on Top 5 Management Failures and Remedies for Success
9. Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
10. CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS)
11. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...9 The following is an investment o...search, Inc. ,, Intellivest Securities Research...visor, has published a Report on BioClinica, Inc. ...al, biotechnology and medical device industries. ... process and submit medical imaging portions of th...
(Date:11/29/2009)...ections begin to form between brain cells almost i...to a study published this week in Nature . Led by...a Cruz, the study involved detailed observations o...ain during motor learning. , The researchers stu...slot to get a seed. They observed rapid growth of ...
(Date:11/29/2009)...nd of treatment equals a $41,000 pay raise, resear...ay News) -- Psychological therapy may be much more...aise or winning a lottery prize, suggests an Engli...nds of people who provided information about their...happiness from a $1,329 course of therapy was so s...
(Date:11/29/2009)...aditional healthcare,s uncertain future and rising...tive care. Affordable Acupuncture Scottsdale answe...vember 29, 2009 -- Affordable Acupuncture, LLC ope...has been met with enthusiasm and gratitude. Its in...buted to two things, need and cost. "As far ...
(Date:11/28/2009)...ikely to consider change after 30-minute psychosoc..., Nov. 27 (HealthDay News) -- A program that gets ...ld stop their dangerous behavior may lead to signi...found. , The new study included 184 men and wom...ions, who were randomly assigned to one of two int...
Breaking Medicine News(10 mins):Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Drunk Drivers May Respond to Brief Motivational Interview 2
...ov. 8 The Connecticut,Trial Lawyers Association (...aling that, for several years Connecticut Medical ... excessive premiums causing their overhead,to soar...nt actuarial firm, is based on the most recent fin...
...Nov. 8 University,HealthSystem Consortium (UHC), ...pitals and health systems, has signed a new five-y...; TSX: TOC) for its comparative,database and bench...evaluate their,performance, compare it to other or...
...enry Ford Hospital is hosting a,day-long program f...provide,up-to-date information on stroke preventio... quality of life. The program, sponsored by the d... Henry Ford Hospital has been designated a Stroke,...
...procedure from Colorado-based company, DENVER, No...s patent-pending Regenexx(TM) procedure, which use...d cartilage -- a welcome relief for the,more than ...vailable today," said Chris Centeno, M.D., creator...
...Y, November 8, 2007- Telemedicine and e-Health, a ... Ann Liebert Inc., publishers ( www.liebertpub.com...eginning in 2008; a new section, MEDICAL CONNECTIV...sions, case studies, interviews with leaders in th...
... the worlds largest molecular imaging and nuclear ...ar $24,000 fellowship program in the United States...eir career. , The SNM Wagner-Torizuka Fellowship...ant contributions to the field of molecular imagin...
Other Medicine News:Health News:Connecticut Trial Lawyers Ask Doctors to Question Insurer's Excess Profits 2Health News:Contract Renewal Extends Thomson Healthcare's Long-Standing Relationship with University Hospitals 2Health News:New Non-Surgical Stem-Cell Procedure Relieves Degenerative Joint Disease 2Health News:Telemedicine publication expands coverage 2Health News:SNM/Nihon Medi-Physics sponsor new fellowship program for Japanese physicians 2
(Date:11/25/2009)... , , PHILADELPHIA, Nov. 25 /PRNewswi...oday that Dr. Michael J. McKelvey, the Company,s P... Executive Vice President and CFO, are scheduled t...Care Conference at 1:30 PM EST on December 1, 2009...ies may access the presentation by visiting the Co...
(Date:11/25/2009)... , , BRIDGEWATER, N.J., Nov. 25 /PRNewswir...ELENCE® (etravirine) tablets, a non-nucleosid...CE is the only NNRTI specifically indicated for us...cing virologic failure with HIV-1 strains resistan...s. The traditional approval is based on 48-week d...
(Date:11/25/2009)... , , RANCHO CORDOVA, Calif., Nov. 25 /PRN...idiary of American Pacific Corporation (Nasdaq: A...mental Responsibility and Sustainability Award at ...ed by the California Manufacturers and Technology ...ssociation (IEA) and the Chemical Industry Council...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Michigan Life Science and Innovation Center Opens in Former Pfizer Facility 5064 1Michigan Life Science and Innovation Center Opens in Former Pfizer Facility 5064 2Michigan Life Science and Innovation Center Opens in Former Pfizer Facility 5064 3Results from Abbotts PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease 5062 1Results from Abbotts PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease 5062 2Results from Abbotts PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease 5062 3Results from Abbotts PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease 5062 4Environmental Chemicals May Affect Male Reproduction 58306 1Environmental Chemicals May Affect Male Reproduction 58306 2
...K, Calif.--(BUSINESS WIRE)--Jun,4, 2007 - ChemGene...ed today the presentation of data from its Quiname...scalation study,designed to identify a genotypica...ted patients with a variety of solid tumors. The,k... that dose level,could be optimised according to p...
... of progression-free survival,in the SPARC Phase 3...ative risk of disease progression for patients rec...Taxotere use,geographies, as well as presence or ...ssion in the SPARC trial - radiologic,progression ... 36%,reduction in relative risk of disease progres...
Other Medicine Technology:ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 2ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 3ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7
Intradyn TearAway
KELLER-TIMMERMANS Introducer Set
CHECK-FLO Performer Introducers CHILDRENS HOSPITAL BOSTON Modification
FLEXOR CHECK-FLO Introducer Sets for Radial Artery Access with AQ Hydrophylic Coating
Medicine Products: